Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Controlled, Randomized, First-In-Human Study of AP31969 Investigating Single and Multiple Ascending Doses and the Effect of Food in Healthy Subjects

NCT06066099 is registered in ClinicalTrials.gov with Acesion Pharma as lead sponsor.

NCT NCT06066099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06066099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Controlled, Randomized, First-In-Human Study of AP31969 Investigating Single and Multiple Ascending Doses and the Effect of Food in Healthy Subjects
Lead sponsor
Acesion Pharma
Phase
Phase 1
Overall status
Completed
Start date
October 4, 2023
Completion date
March 14, 2025
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers